Global hospital acquired infections diagnostics market is
expected to reach USD 11.6 billion by 2022, according to a new report by Grand
View Research, Inc.
The global hospital acquired infections
diagnostics market is projected to grow at a healthy CAGR during the period of
2015 to 2022. Factors attributing to the growth of the market are increase in
the number of drug-resistant pathogens such as MRSA and C. difficile,
advancing age of geriatric population, and development of technologically
advanced products that offer accurate and reliable results with low turnaround
time.
Another factor contributing to industry growth
is the increasing demand of HAI diagnostics from middle and low income
countries, further driving demand for HAI diagnostic market. Increasing
awareness among healthcare workers and proposed government initiatives are further
supporting industry growth. However, decline in the prevalence rate of
nosocomial infections in the developed countries is likely to hinder industry
growth.
The HAI diagnostics market is categorized on
the basis of infection type and test type. On the basis of infection type, the
market is segmented into Urinary Tract Infection (UTI), Blood Stream Infection
(BSI), Surgical Site Infection (SSI), pneumonia, and others. As of 2015, the
urinary tract infection segment was estimated to account for the largest share,
whereas the pneumonia HAI diagnostics is projected to grow at the highest CAGR
during the period of 2015 to 2022.The HAI diagnostics industry is further
segmented into molecular tests and other in-vitro tests. Though the molecular
diagnostics segment is estimated to constitute a low share, it is anticipated
to witness a lucrative growth in the next few years.
Browse full research report on Hospital
Acquired Infections Diagnostics Market:
https://www.grandviewresearch.com/industry-analysis/hospital-acquired-infections-hai-diagnostics-market
Further key
findings from the study suggest:
- In the year 2015, North America held the
largest share in the industry in terms of value. The rising awareness of
HAI, application of technologically advanced products, and significant
measures taken by the government to counter HAIs are some of the major
factors contributing to industry growth.
- The AsiaPacific is projected to witnessthe highest
growth in the coming years, as incidence of HAIs is on rise in the region.
This market is projected to grow rapidly at the highest CAGR of around 20%
during the period 2015 to 2022.
- As of 2015, the diagnostic market for UTI
acquired in hospitals led the industry at a global level. On the other
hand, the pneumonia segment is expected to witness the highest growth over
the forecast period.
- The industry constitutes of numerous local and
global players. Some key players of this market include bioMérieux, Abbott
Laboratories, Roche AG, and Siemens Healthcare among others.
Browse request sample of this report by
Grand View Research:
https://www.grandviewresearch.com/industry-analysis/hospital-acquired-infections-hai-diagnostics-market/request/rs1
Grand
View Research has segmented the global hospital acquired infections diagnostic
market on the basis of infection type, test type, and region:
Hospital
Acquired Infections Diagnostic Infection Type Outlook (Revenue, USD Million,
2012 - 2022)
- Bloodstream
Infections (BSI)
- Urinary Tract
Infections (UTI)
- Surgical Site
Infections (SSI)
- Pneumonia
- Others
Hospital
Acquired Infections Diagnostic Test Type Outlook (Revenue, USD Million, 2012 -
2022)
- Molecular
Diagnostics Tests
- Other In-vitro
Diagnostic Tests
Hospital
Acquired Infections Diagnostic Regional Outlook (Revenue, USD Million, 2012 -
2022)
- North America
- Europe
- AsiaPacific
- Latin America
- MEA
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment